Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2Matthias Tenbusch, Monika Wytopil, Kilian Schober et al.|The Lancet Infectious Diseases|2021Cited by 133
Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infectionK Wagner, Dirk H. Busch, Laura M. Mateyka et al.|Cell Reports|2021Cited by 42
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Emanuel Vogel, Matthias Tenbusch, Katharina Kocher et al.|EBioMedicine|2022Cited by 30
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNAMatthias Tenbusch, Ulrike Protzer, Sofie Schumacher et al.|medRxiv|2021Cited by 5
Recruitment of highly functional SARS-CoV-2-specific CD8 <sup>+</sup> T cell receptors mediating cytotoxicity of virus-infected target cells in non-severe COVID-19K Wagner, Dirk H. Busch, Laura M. Mateyka et al.|medRxiv|2021Cited by 3